[Jefferson Home] [Hospital] [Jefferson Pulse] [Employment] [Contact Us] [Search] [News]

TJU | JMC logo
The Bottom Line: Achieving Diabetes Treatment Goals
VOLUME 1 ISSUE 1
CASE KM
VOLUME 1 ISSUE 2
CASE WM
VOLUME 1 ISSUE 3
CASE SW
VOLUME 1 ISSUE 4
CASE JJ
CASE JJ
EDITORS
CME INFORMATION
DISCLAIMER
REFERENCES
VOLUME 1 ISSUE 5
CASE PD
VOLUME 1 ISSUE 6
CASE MP


CME INFORMATION

VOLUME 1 ISSUE 4 CASE JJ

CME Instruction

  1. Review the learning objectives to determine if the content relates to your individual learning needs.

  2. Read the material carefully, paying particular attention to the figures and the tables.

  3. After reading the material, answer each of the post-test questions on the answer sheet.

  4. Complete the CME Registration Form. Please enter your full name and address in the space provided. Please do not use ALL CAPS or all lower case.

  5. Complete the CME Evaluation Form. Evaluation of the activity is integral to the CME process. CME certificate requests cannot be processed if the Evaluation portion is not completed.
Your answer sheet will be graded, and you will be advised if you have passed or failed. A minimum score of 80 percent correct must be obtained in order for credit to be awarded. Credit for this CME activity is available until its expiration date. There is no fee for participation. Time needed to complete this activity is estimated at no more than one hour.

Be sure to complete this CME activity on or before the expiration date. Check the CME Instructions for each case study for its expiration date. After that date, it will no longer be designated for credit. CME Registration Forms received after this date cannot be processed.

Target Audience

This activity is designed for primary care physicians who treat patients with type 2 diabetes.

Learning Objectives

After reading this case presentation and answering the accompanying questions, the participant should be able to:

  1. Identify risk factors for the development of diabetic nephropathy.
  2. List current screening methods for diabetic nephropathy and the appropriate schedule for their use in patients with type 2 diabetes.
  3. Describe the link between microalbuminuria and cardiovascular disease.
Accreditation

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Jefferson Medical College and BioCentric, Inc.

Jefferson Medical College of Thomas Jefferson University, as a member of the Consortium for Academic Continuing Medical Education, is accredited by the ACCME to provide continuing medical education for physicians.

Jefferson Medical College designates this educational activity for a maximum of one (1) Category 1 credit towards the AMA Physician’s Recognition Award. Each physician should claim only those credits that he/she actually spent on the educational activity.

The Bottom Line (Diabetes) has been approved by the American Academy of Family Physicians as having educational content acceptable for 6 Prescribed credit hours. Term of approval covers issues within one year from distribution date of 3-31-03. This (volume/issue) has been approved for up to 1 Prescribed credit hours. Credit may be claimed for one year from date of this issue.

For information about CME credit, please call the Office of CME, Jefferson Medical College at 888-JEFF-CME.

You may also view this and future newsletters at:
http://jeffline.jefferson.edu/diabetes/newsletters/TheBottomLine

Editors’ Disclosure

Barry J. Goldstein, MD, PhD
Grant/Research Support: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, GlaxoSmithKline, Pfizer Inc., Takeda Pharmaceuticals
Consultant: AstraZeneca Pharmaceuticals LP, GlaxoSmithKline
Scientific Advisory: Aventis, GlaxoSmithKline, Bristol-Myers Squibb Company, AstraZeneca Pharmaceuticals LP
Speakers Bureau: Aventis, Bristol-Myers Squibb Company, GlaxoSmithKline

Richard C. Wender, MD
Consultant: Aventis, GlaxoSmithKline

Samuel Dagogo-Jack, MD, FRCP
Grant/Research Support: Pfizer Inc., Aventis
Consultant: Eli Lilly & Company, GlaxoSmithKline, Novartis
Speakers Bureau: Bristol-Myers Squibb Company


THIS ACTIVITY IS SUPPORTED BY AN UNRESTRICTED EDUCATIONAL GRANT FROM
JOINTLY SPONSORED BY  |  TJU | JMC logo  |  BIOCENTRIC INC logo


The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.

Return to Thomas Jefferson University Home Page